# Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer

> **NCT00002967** · PHASE3 · COMPLETED · sponsor: **NSABP Foundation Inc**

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** cyclophosphamide
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** octreotide pamoate
- **DRUG:** tamoxifen citrate

## Key facts

- **NCT ID:** NCT00002967
- **Lead sponsor:** NSABP Foundation Inc
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-05
- **Primary completion:** —
- **Final completion:** 2006-03
- **Target enrollment:** — (—)
- **Last updated:** 2013-06-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002967, "Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00002967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*